Europe Epigenetics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 14.50 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Epigenetics Market Analysis
The European epigenetics market is expected to register a CAGR of nearly 14.5% over the forecast period. Factors that are responsible for the growth of this market include the increasing incidence and prevalence of cancer, the increasing funding for R&D in healthcare, and rising epigenetic applications in non-oncology diseases.
The epigenetics market is increasing in the European region. For instance, according to WHO, more than 3.7 million new cases of cancer and 1.9 million deaths occur due to cancer every year, and cancer represents the second most important cause of death and morbidity in the European region. Epigenetics is used in the study of changes in gene expression, which are useful in cancer diagnosis. This depicts the large pool of cancer patients, which will propel the growth of the epigenetics market. So, with the increasing cancer prevalence, the market is expected to grow. However, factors, such as the rising cost of instruments are expected to restrain the growth of the market.
Europe Epigenetics Market Trends
This section covers the major market trends shaping the Europe Epigenetics Market according to our research experts:
Oncology is Expected to Grow Faster in the Application Segment
In the last few years, the market has been a golden age for cancer genetics. The cost of gene sequencing has dropped low enough for researchers to read the genomes of many thousands of patients, comparing the DNA of the diseased and healthy tissues to find the mutations associated with tumor formation and growth, which is associated with cancer. The epigenetic innovations are unobtrusively crafting a toolbox for the powerful drugs to treat cancer. And the rising prevalence of cancer in the European region is expected to drive the oncology application in the European epigenetic market.
Europe Epigenetics Industry Overview
The European epigenetic market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. . Some of the major players of the market are Merck & Co., Qiagen, Roche, Thermo Fisher Scientific, and Illumina Inc., among others.
Europe Epigenetics Market Leaders
-
Illumina Inc.
-
Merck & Co. Inc.
-
QIAGEN
-
Thermo Fisher Scientific
-
Zymo Research Corporation
*Disclaimer: Major Players sorted in no particular order
Europe Epigenetics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Incidence and Prevalence of Cancer
- 4.2.2 Increasing Funding for R&D in Healthcare
- 4.2.3 Rising Epigenetic Applications in Non-Oncology Diseases
-
4.3 Market Restraints
- 4.3.1 Rising Cost of Instruments
- 4.3.2 Dearth of Skilled Researchers
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 By Kits
- 5.1.1.1 Bisulfite Conversion Kits
- 5.1.1.2 Chip-seq Kits
- 5.1.1.3 RNA Sequencing Market
- 5.1.1.4 Whole Genome Amplification Market
- 5.1.1.5 5-HMC and 5-MC Analysis Kits
- 5.1.1.6 Other Kits
- 5.1.2 By Reagents
- 5.1.2.1 Antibodies
- 5.1.2.2 Buffers
- 5.1.2.3 Histones
- 5.1.2.4 Magnetic Beads
- 5.1.2.5 Primers
- 5.1.2.6 Other Reagents
- 5.1.3 By Enzymes
- 5.1.3.1 DNA - Modifying Enzymes
- 5.1.3.2 Protein Modifying Enzymes
- 5.1.3.3 RNA Modifying Enzymes
- 5.1.4 By Instruments
- 5.1.4.1 Mass Spectrometer
- 5.1.4.2 Sonicators
- 5.1.4.3 Next Generation Sequencers
- 5.1.4.4 Other Instruments
-
5.2 By Application
- 5.2.1 Oncology
- 5.2.2 Non-Oncology
- 5.2.2.1 Inflammatory Diseases
- 5.2.2.2 Metabolic Diseases
- 5.2.2.3 Infectious Diseases
- 5.2.2.4 Cardiovascular Diseases
- 5.2.2.5 Other Non-Oncology Applications
- 5.2.3 Developmental Biology
- 5.2.4 Other Research Areas
-
5.3 By Technology
- 5.3.1 DNA Methylation
- 5.3.2 Histone Methylation
- 5.3.3 Histone Acetylation
- 5.3.4 Large noncoding RNA
- 5.3.5 MicroRNA modification
- 5.3.6 Chromatin Structures
-
5.4 Geography
- 5.4.1 Europe
- 5.4.1.1 Germany
- 5.4.1.2 UK
- 5.4.1.3 France
- 5.4.1.4 Italy
- 5.4.1.5 Spain
- 5.4.1.6 Rest of Europe
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Diagenode Inc.
- 6.1.2 Epitherapeutics
- 6.1.3 Illumina, Inc.
- 6.1.4 Merck & Co.
- 6.1.5 Qiagen
- 6.1.6 F. Hoffmann-La Roche AG
- 6.1.7 Thermo Fisher Scientific
- 6.1.8 Zymo Research Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityEurope Epigenetics Industry Segmentation
Epigenetics is defined as the study of changes in gene expression, which are caused by certain base pairs in DNA, or RNA, being turned off or on again, through the chemical reactions. This report forecasts revenue growth at country levels and provides an analysis of industry trends in each of the sub - segments from 2017 to 2025. For the purpose of this study, Mordor Intelligence has segmented the Europe epigenetics market report on the basis of product, technology, application, and country.
Europe Epigenetics Market Research FAQs
What is the current Europe Epigenetics Market size?
The Europe Epigenetics Market is projected to register a CAGR of 14.5% during the forecast period (2024-2029)
Who are the key players in Europe Epigenetics Market?
Illumina Inc., Merck & Co. Inc., QIAGEN, Thermo Fisher Scientific and Zymo Research Corporation are the major companies operating in the Europe Epigenetics Market.
What years does this Europe Epigenetics Market cover?
The report covers the Europe Epigenetics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Epigenetics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Epigenetics Industry Report
Statistics for the 2024 Europe Epigenetics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Epigenetics analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
